Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New first-aid method could prevent brain damage in patients exposed to carbon monoxide

04.12.2002


A new first-aid method of treating carbon monoxide poisoning could prevent brain damage in patients by delivering more oxygen to the brain than the standard treatment, according to a study by physicians at the Toronto General Hospital, University Health Network (UHN).



The study is published in the December issue of the U.S. based and peer-reviewed journal Annals of Emergency Medicine. The researchers, led by Dr. Josh Rucker, a Toronto General Hospital research fellow and resident in the Anesthesiology training program at the University of Toronto, studied 14 subjects who were exposed to low levels of carbon monoxide (resulting in blood levels about equal to those in heavy smokers) on two occasions in order to simulate conditions during carbon monoxide poisoning.

After each exposure, which lasted one hour, the participants were given one of two "test treatments": the standard treatment of 100% oxygen, or the new method consisting of a mixture of mostly oxygen and some carbon dioxide. Each participant received both test treatments in random order. Researchers then monitored the amount of oxygen in the blood and the blood flow to the brain during exposure to carbon monoxide and during the test treatments.


KEY RESULTS

  • During the standard treatment with 100% oxygen, the flow of blood to the brain diminished, decreasing oxygen delivery to the brain. Results showed that the blood flow decreased by up to 33% and the oxygen delivered to the brain decreased by up to 20%.

  • Such a decrease in blood flow to the brain is sufficient to contribute to brain damage in a patient with severe carbon monoxide poisoning.

  • However, during treatment with the combination of oxygen and carbon dioxide, two effects were observed:

  • The delivery of oxygen to the brain was greater than during treatment with oxygen alone;

  • The rate of elimination of carbon monoxide increased by more than 20%.

"These results are intriguing," said Dr. Fisher, an anesthesiologist at Toronto General Hospital, University Health Network, Associate Professor in the Faculty of Medicine at the University of Toronto and a senior author of the study. "Most doctors believe that giving patients oxygen is like giving them chicken soup -- it can’t hurt. But, in fact, we find that treating carbon monoxide-exposed participants with pure oxygen actually limits the amount of oxygen that gets to their brains. That is worrisome."

"If severely poisoned patients respond like our test subjects, this new first-aid treatment may decrease the extent of brain damage in survivors," added Dr. Joseph Fisher.

IMPLICATIONS

  • This study raises the possibility that the standard first-aid treatment of carbon monoxide poisoning -- 100% oxygen - constricts blood vessels to the brain and decreases the total oxygen delivered to the brain.

  • Researchers think that the small amount of carbon dioxide in the oxygen counteracts the constriction of blood vessels to the brain

  • Although clinical studies need to be completed before recommending a change in the first-aid treatment of carbon monoxide poisoning, the results of this study suggest that simply maintaining carbon dioxide levels during treatment will result in more oxygen delivery to the brain, thereby decreasing the risk of permanent brain damage in severely poisoned patients.

  • Note: Adding carbon dioxide to oxygen during treatment for carbon monoxide poisoning was common in the late 1920s and 1930s.

  • It was thought then that the carbon dioxide stimulated breathing, helping to eliminate carbon monoxide more quickly, but was discontinued in the late 1940s when mechanical ventilators became available.

  • This study supports the re-introduction of this practice in order to maintain blood flow and oxygen delivery to the brain.

CARBON MONOXIDE POISONING

  • Carbon monoxide is the leading cause of fatal poisoning in the industrialized world, as well as being endemic in many parts of the developing world which use fossil fuels

  • In North America, it results in as many as 70,000 emergency room visits a year and in thousands of deaths

  • Up to 30 per cent of survivors of severe poisoning are left with disabling psychological and neurological symptoms, which sometimes last for years

  • Carbon monoxide is an odorless colorless gas formed during incomplete combustion of the fossil fuels - gas, oil, coal and wood used in boilers, engines, gas fires, water heaters, solid fuel appliances and open fires

  • When carbon monoxide is inhaled--even in tiny concentrations--it combines with the hemoglobin in the red blood cells to prevent the delivery of oxygen to the body

  • This results in few symptoms until the poisoning is advanced

  • Those suffering from carbon monoxide poisoning may initially complain of headache, nausea and fatigue but the symptoms can rapidly progress to coma and even death

  • It is therefore critical that carbon monoxide be eliminated from the body as soon and as quickly as possible

  • The only currently available emergency treatment for carbon monoxide poisoning is giving the patient 100 per cent oxygen


The study was supported, in part, by the Department of Anesthesia, University Health Network and the University of Toronto, and the Tobi and Ted Bekhor Foundation.

The Toronto General Hospital is a partner in University Health Network, along with Toronto Western and Princess Margaret Hospitals. The scope of research and complexity of cases at Toronto General Hospital has made it a national and international source for discovery, education and patient care. It has one of the largest hospital-based research programs in Canada, with major research projects in cardiology, transplantation, surgical innovation, infectious diseases, and genomic medicine. Toronto General Hospital is a teaching hospital affiliated with the University of Toronto.

To schedule an interview with Dr. Josh Rucker or Dr. Joseph Fisher, please contact:

Alex Radkewycz
Public Affairs
Toronto General Hospital, University Health Network
Phone: 416-340-3895
Pager: 416-980-0752

Marlene de Chellis | EurekAlert!

More articles from Health and Medicine:

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

nachricht Study advances gene therapy for glaucoma
17.01.2018 | University of Wisconsin-Madison

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Morbid Obesity: Gastric Bypass and Sleeve Gastrectomy Are Comparable

17.01.2018 | Health and Medicine

Researchers identify new way to unmask melanoma cells to the immune system

17.01.2018 | Health and Medicine

Genetic discovery may help better identify children at risk for type 1 diabetes

17.01.2018 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>